Corcept Therapeutics, Inc. (CORT)
113.35
-0.53
(-0.47%)
USD |
NASDAQ |
Aug 31, 16:00
113.34
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Cash from Operations (TTM) : 109.70M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 109.70M |
| March 31, 2026 | 120.10M |
| December 31, 2025 | 141.64M |
| September 30, 2025 | 162.49M |
| June 30, 2025 | 181.84M |
| March 31, 2025 | 179.08M |
| December 31, 2024 | 198.07M |
| September 30, 2024 | 144.65M |
| June 30, 2024 | 123.73M |
| March 31, 2024 | 124.84M |
| December 31, 2023 | 127.04M |
| September 30, 2023 | 154.54M |
| June 30, 2023 | 135.28M |
| March 31, 2023 | 111.03M |
| December 31, 2022 | 120.32M |
| September 30, 2022 | 136.36M |
| June 30, 2022 | 151.42M |
| March 31, 2022 | 177.72M |
| December 31, 2021 | 167.89M |
| September 30, 2021 | 153.54M |
| June 30, 2021 | 135.28M |
| March 31, 2021 | 144.12M |
| December 31, 2020 | 151.97M |
| September 30, 2020 | 165.35M |
| June 30, 2020 | 173.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 145.70M |
| December 31, 2019 | 136.12M |
| September 30, 2019 | 109.18M |
| June 30, 2019 | 115.26M |
| March 31, 2019 | 104.92M |
| December 31, 2018 | 115.66M |
| September 30, 2018 | 119.03M |
| June 30, 2018 | 85.45M |
| March 31, 2018 | 85.80M |
| December 31, 2017 | 60.94M |
| September 30, 2017 | 40.62M |
| June 30, 2017 | 38.63M |
| March 31, 2017 | 24.66M |
| December 31, 2016 | 18.39M |
| September 30, 2016 | 17.98M |
| June 30, 2016 | 9.933M |
| March 31, 2016 | 8.204M |
| December 31, 2015 | 3.13M |
| September 30, 2015 | -2.436M |
| June 30, 2015 | -9.248M |
| March 31, 2015 | -18.09M |
| December 31, 2014 | -27.38M |
| September 30, 2014 | -33.64M |
| June 30, 2014 | -36.31M |
| March 31, 2014 | -36.56M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Liquidia Corp. | 167.71M |
| Eli Lilly & Co. | 28.08B |
| Abeona Therapeutics, Inc. | -76.44M |
| Indivior Pharmaceuticals, Inc. | -48.64M |
| Crinetics Pharmaceuticals, Inc. | -422.52M |